Cutaneous Melanoma of the Extremity — Research

Cutaneous Melanoma of the Extremity — Research · CancerIndex

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

pubmedComputed3 windows · counts computed by CancerIndex from PubMed E-utilities; the exact query is stored with each count.

Window	Period	Records (count)	Exact query	Computed	Source
All time	… → 2026-09-11	5	`("Cutaneous Melanoma of the Extremity"[tiab] OR "Primary Extremity Melanoma"[tiab] OR "Primary Melanoma of the Extremity"[tiab] OR "Primary Cutaneous Melanoma of the Extremity"[tiab])`	2026-09-11	pubmed
Last 5 years	2021-01-01 → 2026-12-31	0	`("Cutaneous Melanoma of the Extremity"[tiab] OR "Primary Extremity Melanoma"[tiab] OR "Primary Melanoma of the Extremity"[tiab] OR "Primary Cutaneous Melanoma of the Extremity"[tiab]) AND (2021/01/01:2026/12/31[dp])`	2026-09-11	pubmed
Last 12 months	2025-09-11 → 2026-09-11	0	`("Cutaneous Melanoma of the Extremity"[tiab] OR "Primary Extremity Melanoma"[tiab] OR "Primary Melanoma of the Extremity"[tiab] OR "Primary Cutaneous Melanoma of the Extremity"[tiab]) AND (2025/09/11:2026/09/11[dp])`	2026-09-11	pubmed

Data updated 19 days agoSource updated unknownsource: pubmed E-utilities

Literature

Linked publications (4)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 1–4 of 4 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

TERT gene amplification is associated with poor outcome in acral lentiginous melanoma.
· J Am Acad Dermatol · 2014 · PMID 25219713 · validated civic_curation pubmed
A Variant in a MicroRNA complementary site in the 3' UTR of the KIT oncogene increases risk of acral melanoma.
· Oncogene · 2011 · PMID 21119596 · validated civic_curation pubmed
Targeting RAF1 gene fusions with MEK inhibition in metastatic melanoma.
· Oncologist · 2025 · PMID 39504576 · validated civic_curation pubmed
Exploring Molecular Genetic Alterations and RAF Fusions in Melanoma: A Belvarafenib Expanded Access Program in Patients with RAS/RAF-Mutant Melanoma.